Ticker Details
Omeros Corporation Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
IPO Date:	October 8, 2009
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$829.42M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.21%
Avg Daily Range (30 D):	$0.34 | 2.56%
Avg Daily Range (90 D):	$0.30 | 2.45%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	1.17M
Avg Daily Volume (90 D):	1.11M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	1,392
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$1.26M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$1.36M
Avg Closing Trade (90 D):	$1.28M
Avg Closing Volume:	122.31K

News

Apr 20, 2026 @ 11:00 AM Sagimet Biosciences Announces Appointment of Andre... Source: Na

Dec 24, 2025 @ 10:22 PM Why Omeros Stock Skyrocketed Today Source: Eric Volkman

Nov 5, 2025 @ 6:30 AM Novo Nordisk's sales increased by 12% in Danish kr... Source: Novo Nordisk

Oct 23, 2025 @ 12:35 PM Breakout Momentum Plays You Need to Know About Source: Nathan Reiff

Oct 22, 2025 @ 5:00 PM Complement 3 Glomerulopathy Market Poised for Phen... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.3	$.78	$1.42
Diluted EPS	$1.14	$.62	$1.42
Revenue	$9.89M	$9.89M	$M
Gross Profit		$9.31M
Net Income / Loss	$86.17M	$56.06M	$86.45M
Operating Income / Loss	$-105.25M	$-17.42M	$-29.08M
Cost of Revenue		$.59M
Net Cash Flow	$-2.36M	$-7.75M	$7.27M
PE Ratio

Splits
Oct 02, 2009	25:49